Company profile
NeuroGenesis Bio Inc.
Pioneering hope and cure to neurodegenerative diseases with advanced cellular therapies
- Industry
- Biotechnology Research
- Employees
- 14
- Headquarters
- Rochester, New York
- Founded
- 2018
- LinkedIn followers
- 1,390
- Office locations
- 2
NeuroGenesis Bio Inc. company summary
NeuroGenesis Bio Inc. is a company in the Biotechnology Research industry, headquartered in Rochester, New York, founded in 2018. On LinkedIn the company has around 14 employees and 1,390 followers. The company lists 2 office locations. Its listed specialties include Cell Therapies, Neurodegenerative Diseases, Biotech.
What technology does NeuroGenesis Bio Inc. use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About NeuroGenesis Bio Inc.
NeuroGenesis Bio Inc. is a clinical-stage cellular therapy company focused on developing novel and effective treatments for neurodegenerative diseases. The company has developed NG01 as a proprietary method to transform a unique subpopulation of marrow-derived cells into bio-factories for sustained delivery of regenerative and neuroprotective proteins. By promoting myelin and neuronal regeneration, the NG01 cellular therapy platform is optimized to treat neurodegenerative diseases such as progressive multiple sclerosis (MS) and amyotrophic lateral sclerosis (ALS). NG01 has been studied extensively in several clinical trials including a successful double blind, randomized, placebo-controlled Phase II study for progressive MS, and two long term (up to 4 years) Phase IIa trials for Progressive MS and ALS. To date, more than 160 progressive MS and ALS patients from around the world have been treated with this breakthrough therapeutic modality. Headquartered in Upstate NY, NeuroGenesis is steadily moving forward with a global, FDA-approved multi-site Phase IIb trial for secondary progressive multiple sclerosis, in partnership with major medical research centers in the United States and abroad. For more information on the company, please visit: https://neurogenesis-cell.com/
Specialties
Where is NeuroGenesis Bio Inc. located?
NeuroGenesis Bio Inc. lists 2 office locations.
Compare companies similar to NeuroGenesis Bio Inc.
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
NeuroGenesis Bio Inc. neurogenesis-cell.com | Biotechnology Research | 14 | 2018 | Rochester, New York |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about NeuroGenesis Bio Inc.
What does NeuroGenesis Bio Inc. do?
NeuroGenesis Bio Inc. is a clinical-stage cellular therapy company focused on developing novel and effective treatments for neurodegenerative diseases. The company has developed NG01 as a proprietary method to transform a unique subpopulation of marrow-derived cells into bio-factories for sustained delivery of regenerative and neuroprotective proteins. By promoting myelin and neuronal regeneration, the NG01 cellular therapy platform is optimized to treat neurodegenerative diseases such as progressive multiple sclerosis (MS) and amyotrophic lateral sclerosis (ALS). NG01 has been studied extensively in several clinical trials including a successful double blind, randomized, placebo-controlled Phase II study for progressive MS, and two long term (up to 4 years) Phase IIa trials for Progressive MS and ALS. To date, more than 160 progressive MS and ALS patients from around the world have been treated with this breakthrough therapeutic modality. Headquartered in Upstate NY, NeuroGenesis is steadily moving forward with a global, FDA-approved multi-site Phase IIb trial for secondary progressive multiple sclerosis, in partnership with major medical research centers in the United States and abroad. For more information on the company, please visit: https://neurogenesis-cell.com/
How many employees does NeuroGenesis Bio Inc. have?
NeuroGenesis Bio Inc. has around 14 employees on LinkedIn.
Where is NeuroGenesis Bio Inc. headquartered?
NeuroGenesis Bio Inc. is headquartered in Rochester, New York.
Where does NeuroGenesis Bio Inc. have offices?
NeuroGenesis Bio Inc. lists 2 office locations, including Rochester, New York, US; Jerusalem, IL, IL.
When was NeuroGenesis Bio Inc. founded?
NeuroGenesis Bio Inc. was founded in 2018.
Build a lead list from companies like NeuroGenesis Bio Inc.
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.